We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$51.8B
AUM Growth
+$2.19B
Cap. Flow
-$1.04B
Cap. Flow %
-2.01%
Top 10 Hldgs %
17.67%
Holding
2,975
New
68
Increased
781
Reduced
1,984
Closed
53

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$102M
2
XL
XL Group Ltd.
XL
+$28.4M
3
MSFT icon
Microsoft
MSFT
+$26.9M
4
CSCO icon
Cisco
CSCO
+$24.2M
5
GGP
GGP Inc.
GGP
+$24M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Financials 15.87%
3 Healthcare 13.94%
4 Consumer Discretionary 10.36%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBTC
2476
DELISTED
Enterprise Bancorp
EBTC
$325K ﹤0.01%
9,441
+67
+0.7% +$2.46K
DMRC icon
2477
Digimarc Corp
DMRC
$171M
$324K ﹤0.01%
10,310
-1,175
-10% -$34.5K
MRNS
2478
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$323K ﹤0.01%
8,087
-588
-7% -$16.7K
IIN
2479
DELISTED
IntriCon Corporation
IIN
$322K ﹤0.01%
5,729
-40
-0.7% -$2.34K
ELOX
2480
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$321K ﹤0.01%
471
-23
-5% -$14.7K
HABT
2481
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$321K ﹤0.01%
20,154
+50
+0.2% +$715
AMNB
2482
DELISTED
American National Bankshares Inc
AMNB
$320K ﹤0.01%
8,211
+61
+0.7% +$2.48K
BLBD icon
2483
Blue Bird Corp
BLBD
$2.09B
$319K ﹤0.01%
13,016
-286
-2% -$6.57K
CPRX
2484
DELISTED
Catalyst Pharmaceutical
CPRX
$319K ﹤0.01%
84,500
-6,225
-7% -$19.5K
CRBP icon
2485
Corbus Pharmaceuticals
CRBP
$180M
$319K ﹤0.01%
1,410
-107
-7% -$17.3K
TUSK icon
2486
Mammoth Energy Services
TUSK
$142M
$319K ﹤0.01%
10,946
+1,717
+19% +$56.6K
ABUS icon
2487
Arbutus Biopharma
ABUS
$897M
$318K ﹤0.01%
33,616
+260
+0.8% +$2.58K
CTSO icon
2488
Cytosorbents Corp
CTSO
$25M
$318K ﹤0.01%
24,630
-1,251
-5% -$15.7K
DSKE
2489
DELISTED
Daseke, Inc. Common Stock
DSKE
$318K ﹤0.01%
39,694
FRBK
2490
DELISTED
Republic First Bancorp Inc
FRBK
$318K ﹤0.01%
44,406
-600
-1% -$4.58K
GEF.B icon
2491
Greif Class B
GEF.B
$4.21B
$317K ﹤0.01%
5,498
+3
+0.1% +$175
SENS icon
2492
Senseonics Holdings Inc
SENS
$269M
$317K ﹤0.01%
3,323
+215
+7% +$17.6K
JCAP
2493
DELISTED
Jernigan Capital, Inc.
JCAP
$317K ﹤0.01%
16,417
+3,329
+25% +$63.4K
RBB icon
2494
RBB Bancorp
RBB
$455M
$315K ﹤0.01%
12,877
+180
+1% +$5.36K
ATEX icon
2495
Anterix
ATEX
$1.96B
$313K ﹤0.01%
9,237
CZNC icon
2496
Citizens & Northern Corp
CZNC
$453M
$313K ﹤0.01%
11,971
+92
+0.8% +$2.52K
GSHD icon
2497
Goosehead Insurance
GSHD
$2.37B
$313K ﹤0.01%
9,250
+547
+6% +$15.9K
FRAN
2498
DELISTED
Francesca's Holdings Corporation
FRAN
$313K ﹤0.01%
7,021
-84
-1% -$6.65K
FRST icon
2499
Primis Financial Corp
FRST
$405M
$312K ﹤0.01%
19,285
+225
+1% +$3.9K
ULH icon
2500
Universal Logistics Holdings
ULH
$485M
$311K ﹤0.01%
8,463
-525
-6% -$17.4K

Similar funds

RhumbLine Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, RhumbLine Advisers held 2,975 positions worth $51.8B, up 4.4% from $49.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 4.1%. RhumbLine Advisers opened 68 new positions and exited 53, leaving the 2,975-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2018 buy was iShares TIPS Bond ETF: 312,303 shares worth $34.5M.
  • RhumbLine Advisers added most to Williams Companies in Q3 2018, an estimated $16.4M increase.
  • RhumbLine Advisers's biggest Q3 2018 reduction was Apple, cutting an estimated $102M.
  • RhumbLine Advisers fully exited XL Group Ltd. in Q3 2018, selling an estimated $28.4M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $51.8B portfolio in Q3 2018.
  • RhumbLine Advisers opened 68 new positions and closed 53 in Q3 2018.
  • RhumbLine Advisers's portfolio value rose 4.4% quarter-over-quarter to $51.8B.

Based on RhumbLine Advisers's 13F filing for Q3 2018, filed 7 Nov 2018.